The solubility of this product is tested in chloroform at 50 mg/mL. Solution stability has not been determined, however the acetate form is unstable in solution and should be prepared fresh. The end user would have to validate solution stability of this compound experimentally. The NIH lists the material as being soluble in ethanol, methanol, ether, and acetone. Please see the link below to review this publication:
https://pubchem.ncbi.nlm.nih.gov/compound/Medroxyprogesterone#section=Color-Form
M6013
Medroxyprogesterone
別名:
17α-Hydroxy-6α-methyl-4-pregnene-3,20-dione, 17α-Hydroxy-6α-methylprogesterone, 6α-Methyl-5-pregnen-17α-ol-3,20-dione, 6-Dihydromegestrol
ログイン組織・契約価格を表示する
すべての画像(3)
About This Item
実験式（ヒル表記法）:
C22H32O3
CAS番号:
分子量:
344.49
Beilstein:
2510965
EC Number:
MDL番号:
UNSPSCコード:
51111800
PubChem Substance ID:
NACRES:
NA.77
現在、価格および在庫状況を閲覧できません。
おすすめの製品
由来生物
synthetic (organic)
アッセイ
≥98% (HPLC)
フォーム
powder
溶解性
chloroform: 50 mg/mL, clear, colorless to faintly yellow
輸送温度
ambient
保管温度
room temp
SMILES記法
[H][C@@]12C[C@H](C)C3=CC(=O)CC[C@]3(C)[C@@]1([H])CC[C@@]4(C)[C@@]2([H])CC[C@]4(O)C(C)=O
InChI
1S/C22H32O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h12-13,16-18,25H,5-11H2,1-4H3/t13-,16+,17-,18-,20+,21-,22-/m0/s1
InChI Key
FRQMUZJSZHZSGN-HBNHAYAOSA-N
遺伝子情報
rat ... Ar(24208)
類似した製品をお探しですか？ 訪問 製品比較ガイド
注意
多くの薬理学の文献が酢酸メドロキシプロゲステロンをメドロキシプロゲステロンと呼んでいますが、この2つはもちろん異なる物質です。
関連製品
シグナルワード
Warning
危険有害性情報
危険有害性の分類
Repr. 2
保管分類コード
11 - Combustible Solids
WGK
WGK 3
個人用保護具 (PPE)
Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
M6013-VAR:
M6013-1G:
M6013-BULK:
M6013-250MG:
Adarsh J Sai et al.
Menopause (New York, N.Y.), 18(10), 1101-1112 (2011-06-30)
The aim of this study was to examine the effect of conjugated equine estrogens alone (ET), conjugated equine estrogens + medroxyprogesterone (EPT), calcitriol alone, calcitriol + EPT/ET, or placebo on serum lipid profile and analyze the interaction with estrogen receptor-α
Clinical significance of differences in bioavailability of medroxyprogesterone acetate preparations.
A D Stockdale et al.
Clinical pharmacokinetics, 16(3), 129-133 (1989-03-01)
M F Fung et al.
Obstetrics and gynecology, 78(6), 1033-1038 (1991-12-01)
We conducted a retrospective review of 44 patients with metastatic or recurrent endometrial carcinoma treated with cisplatin, doxorubicin, cyclophosphamide, and medroxyprogesterone acetate. Thirty-six women had metastatic disease; eight had recurrent disease. In the metastatic group, 12 women had positive peritoneal
Toshio Hayashi et al.
Nitric oxide : biology and chemistry, 24(4), 199-203 (2011-04-26)
A comparison between the atheroprotective and osteoprotective effects of the selective estrogen receptor modulator (SERM) raloxifene and those of hormone replacement therapy (HRT) has not been made in elderly women. A randomized prospective controlled trial was performed in a cohort
Carolyn J Crandall et al.
Breast cancer research and treatment, 132(1), 275-285 (2011-11-02)
The associations between breast tenderness during use of conjugated equine estrogen (CEE) therapy with or without medroxyprogesterone (MPA) therapy and subsequent breast cancer risk are unknown. We analyzed data from the Women's Health Initiative Estrogen plus Progestin (N = 16,608
-
is there is any other solution can be used to dissolve the Medroxyprogesterone and whats the tempreture we need to use for stoarge after dissolving the Medroxyprogesterone
1 回答-
役に立ちましたか？
-
アクティブなフィルタ
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）
